Andrea Park

The CDC seems to be taking an “if it ain't broke” approach to its annual flu vaccine push.

Patient groups typically form around specific disease areas with an aim of advocating for improved treatments and therapies for patients who fall into those categories—and they’re feeling the wides

A new survey shows that three Big Pharmas have stolen the hearts of patient groups representing nearly 1 million people with cardiovascular conditions.

Not long after Basel, Switzerland, was selected as the next host of the annual Eurovision Song Contest, hometown pharma Novartis is chiming in.

As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD.

Each year, we dive into the world of biotech closures and layoffs, tracking the industry's pulse as companies navigate high risks and harsh realities.

The introduction of biologic therapies for hidradenitis suppurativa (HS) has “revolutionized” treatment for the rare inflammatory skin condition, though there's still plenty of progress to be made, according to Spherix Global Insights.

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, which is approved by

As National Diabetes Month gets underway, StrideMD is among the diabetes care providers, tech developers and drugmakers helping raise awareness of the condition.

As the rollout of its recently launched pulmonary arterial hypertension (PAH) drug Winrevair ramps up, Merck is continuing its work to improve awareness of and education around the rare disease.